COVID-19

March 26, 2021

Aspirin Use Is Associated With Decreased Mechanical Ventilation, Intensive Care Unit Admission, and In-Hospital Mortality in Hospitalized Patients With Coronavirus Disease 2019 | Post-acute COVID-19 syndrome | Are vaccines safe in patients with Long COVID? A prospective observational study

March 19, 2021

Lilly’s bamlanivimab and etesevimab together reduced hospitalizations and death in Phase 3 trial for early COVID-19 | Ridgeback Biotherapeutics and Merck Announce Preliminary Findings from a Phase 2a Trial of Investigational COVID-19 Therapeutic Molnupiravir

March 8, 2021

Difference in SARS-CoV-2 attack rate between children and adults may reflect bias | Update on long COVID prevalence estimate | Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19 | Dexamethasone in Hospitalized Patients with Covid-19

March 3, 2021

Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts | Inhaled budesonide in the treatment of early COVID-19 illness: a randomised controlled trial | Sequelae in Adults at 6 Months After COVID-19 Infection

February 22, 2021

Early initiation of prophylactic anticoagulation for prevention of coronavirus disease 2019 mortality in patients admitted to hospital in the United States: cohort study | Multisystem Inflammatory Syndrome in Children (MIS-C) | Decreased SARS-CoV-2 viral load following vaccination

February 8, 2021

Full-dose blood thinners decreased need for life support and improved outcome in hospitalized COVID-19 patients | Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization | Single Dose Vaccination in Healthcare Workers Previously Infected with SARS-CoV-2

February 1, 2021

Novavax COVID-19 Vaccine Demonstrates 89.3% Efficacy in UK Phase 3 Trial | Johnson & Johnson Announces Single-Shot Janssen COVID-19 Vaccine Candidate Met Primary Endpoints in Interim Analysis of its Phase 3 ENSEMBLE Trial | SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19

January 25, 2021

COVID-19 Symptoms: Longitudinal Evolution and Persistence in Outpatient Settings | The impact of Spike mutations on SARS-CoV-2 neutralization | Vitamin D Status is Associated With In-hospital Mortality and Mechanical Ventilation: A Cohort of COVID-19 Hospitalized Patients

January 18, 2021

SARS-CoV-2 encephalitis is a cytokine release syndrome: evidence from cerebrospinal fluid analyses | Evolution of antibody immunity to SARS-CoV-2 | Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine | Structure-guided multivalent nanobodies block SARS-CoV-2 infection and suppress mutational escape

January 11, 2021

SARS-CoV-2 Viral Load on Admission Is Associated With 30-Day Mortality | Cognitive deficits in people who have recovered from COVID-19 relative to controls: An N=84,285 online study | Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)

Receive updates about Parasites without Borders initiatives, developments, and learn more about parasites by subscribing to our periodic newsletter.


By submitting this form, you are consenting to receive marketing emails from: . You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Parasites Without Borders

A comprehensive educational resource on all aspects of parasitic diseases and their impact on humanity around the globe.

Donate to Parasites Without Borders today!

Help bring the latest medical and basic biological information pertaining to diseases caused by eukaryotic parasites to every practicing physician and medical student within the United States.

Scroll to Top